ArcBest Target Price

See ArcBest's analyst price targets ($170) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$132.72

Average Target Price

$166.00

25.1% upside

5 analysts in the last 4 months

High: $176 | Low: $154

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-08	Stifel Nicolaus	$168	26.6% upside
2026-10-07	Truist FinancialLucas Servera	$160	20.6% upside
2026-08-03	UBSThomas Wadewitz	$154	16% upside
2026-07-29	Goldman Sachs	$172	29.6% upside
2026-07-21	Stifel Nicolaus	$176	32.6% upside
2026-07-07	UBS	$145	9.3% upside
2026-07-06	Morgan StanleyRavi Shanker	$180	35.6% upside
2026-06-23	Goldman SachsJordan Alliger	$165	24.3% upside
2026-06-05	Wells Fargo	$150	13% upside
2026-04-29	Truist Financial	$145	9.3% upside
2026-04-29	Morgan Stanley	$150	13% upside
2026-04-29	UBSThomas Wadewitz	$122	8.1% downside
2026-04-28	Goldman Sachs	$117	11.8% downside
2026-04-16	Stifel Nicolaus	$116	12.6% downside
2026-02-04	UBSThomas Wadewitz	$98	26.2% downside
2026-02-02	Stifel NicolausBruce Chan	$94	29.2% downside
2026-02-01	Wells Fargo	$85	36% downside
2026-01-31	Goldman SachsJordan Alliger	$100	24.7% downside
2026-01-21	Stifel Nicolaus	$96	27.7% downside
2026-01-15	Truist Financial	$95	28.4% downside
2026-01-06	StephensReed Seay	$85	36% downside
2025-10-28	Stifel Nicolaus	$85	36% downside
2025-09-30	UBS	$80	39.7% downside
2025-07-31	Stifel NicolausBruce Chan	$81	39% downside
2025-02-03	Morgan StanleyRavi Shanker	$145	9.3% upside
2024-10-09	CitigroupAriel Rosa	$111	16.4% downside
2024-08-06	Stifel NicolausBruce Chan	$131	1.3% downside
2024-07-08	Morgan StanleyRavi Shanker	$176	32.6% upside
2024-05-14	Stifel NicolausBruce Chan	$150	13% upside
2024-05-01	UBSThomas Wadewitz	$126	5.1% downside
2023-08-01	Stifel NicolausBruce Chan	$134	1% upside
2023-02-06	Credit Suisse	$100	24.7% downside
2023-01-11	Morgan Stanley	$138	4% upside

ArcBest (ARCB) FAQ

ArcBest (ARCB) currently reports a target price of $170. Use the charts on this page to explore ArcBest's target price history and peer comparisons.

Analysts' average 12-month price target for ArcBest is $170, about 25.1% upside from the current share price of $132.72. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $170, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ArcBest, and consider following ARCB for alerts when major investors trade the stock.

ArcBest is classified in the Industrials sector. On target price, it currently shows $170. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing ARCB with unrelated industries.